Analysis of Anti-Xa-Levels prior to neuroaxial blocks - a retrospective study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00022099

Enrollment

100

Registered

2020-07-10

Start date

2020-06-03

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

D68.9

Interventions

Group 1: Patients with Antifactor Xa determination prior to planned implementation of a neuroaxial blockade

Eligibility

Sex/Gender

All

Age

16 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with Anti-factor Xa level quantification before neuroaxial Anesthesia

Exclusion criteria

Exclusion criteria: Age < 16 years

Design outcomes

Primary

Measure	Time frame
Incidence and risk factors for residual Anti-Factor Xa activity prior to neuroaxial anesthesia after therapeutic anticoagulation with low-molecular weight heparin.	—

Countries

Germany

Contacts

Public ContactAxel Schmutz

Klinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Freiburg

axel.schmutz@uniklinik-freiburg.de0761 270 24010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026